Medicaid Bulletin
Medicaid Bulletin Monthly Digest
Articles beginning January 2018 are available in the blog format.
View Embed
Effective Aug. 18, 2021, the Medicaid and NC Health Choice programs cover anifrolumab-fnia injection
Tobacco-related policy requirements go into effect on July 1, 2022.
Two Months Left to Submit Program Year 2021 Attestations; Security Risk Analysis
Providers are encouraged to confirm which PA types are included in this long-term design.
Will cover all U.S. FDA approved CAR T-Cell Therapies when administered per U.S. FDA approved guidelines
Temporary Suspension of Prior Authorization for Post-Acute Placements and Temporary Availability of the Hospital at Home Program
Casirivimab and Imdevimab have been given emergency use authorization for treatment of mild to moderate COVID-19 in some patients.
Tips for providers to reduce the likelihood of future documentation errors